Revenue: The sum of all revenue fields included for a company's operating activities.
Dianthus Therapeutics, Inc. (DNTH) had Revenue of $1.16M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$1.16M |
$-29.51M |
|
-- |
|
$1.16M |
|
$34.34M |
|
$-33.18M |
|
$3.67M |
|
$-29.51M |
|
$-29.51M |
|
$-29.51M |
|
$-29.51M |
|
$-29.51M |
|
$-29.51M |
|
$-33.18M |
|
$-34.94M |
|
35.79M |
|
35.79M |
|
$-0.82 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$271.00M |
|
$0.19M |
|
$77.58M |
|
$348.58M |
|
$16.95M |
|
-- |
|
$3.02M |
|
$19.97M |
|
$328.61M |
|
$328.61M |
|
$328.61M |
|
32.12M |
|
| Cash Flow Statement Financials | |
$-27.63M |
|
$14.79M |
|
$0.16M |
|
$23.02M |
|
$10.35M |
|
$-12.68M |
|
$5.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2852.71% |
|
-2852.71% |
|
-- |
|
-2537.49% |
|
-2537.49% |
|
$-27.65M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.16 |
|
77.39 |
|
-8.98% |
|
-8.98% |
|
-8.47% |
|
-8.98% |
|
$10.23 |
|
$-0.77 |
|
$-0.77 |
|